BriaCell Therapeutics (BCTX) Competitors $1.16 +0.21 (+21.50%) (As of 11:03 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BCTX vs. MCRB, NBTX, IVA, IFRX, SKYE, RPTX, RENB, TELO, IMUX, and CNTXShould you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include Seres Therapeutics (MCRB), Nanobiotix (NBTX), Inventiva (IVA), InflaRx (IFRX), Skye Bioscience (SKYE), Repare Therapeutics (RPTX), Renovaro (RENB), Telomir Pharmaceuticals (TELO), Immunic (IMUX), and Context Therapeutics (CNTX). These companies are all part of the "pharmaceutical preparations" industry. BriaCell Therapeutics vs. Seres Therapeutics Nanobiotix Inventiva InflaRx Skye Bioscience Repare Therapeutics Renovaro Telomir Pharmaceuticals Immunic Context Therapeutics BriaCell Therapeutics (NASDAQ:BCTX) and Seres Therapeutics (NASDAQ:MCRB) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability. Does the media favor BCTX or MCRB? In the previous week, BriaCell Therapeutics had 7 more articles in the media than Seres Therapeutics. MarketBeat recorded 7 mentions for BriaCell Therapeutics and 0 mentions for Seres Therapeutics. BriaCell Therapeutics' average media sentiment score of 0.52 beat Seres Therapeutics' score of 0.00 indicating that BriaCell Therapeutics is being referred to more favorably in the media. Company Overall Sentiment BriaCell Therapeutics Positive Seres Therapeutics Neutral Is BCTX or MCRB more profitable? Company Net Margins Return on Equity Return on Assets BriaCell TherapeuticsN/A N/A -44.65% Seres Therapeutics N/A N/A -55.08% Which has more risk & volatility, BCTX or MCRB? BriaCell Therapeutics has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500. Comparatively, Seres Therapeutics has a beta of 2.07, suggesting that its stock price is 107% more volatile than the S&P 500. Do insiders & institutionals believe in BCTX or MCRB? 15.4% of BriaCell Therapeutics shares are held by institutional investors. Comparatively, 59.3% of Seres Therapeutics shares are held by institutional investors. 21.8% of BriaCell Therapeutics shares are held by company insiders. Comparatively, 5.1% of Seres Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has better earnings & valuation, BCTX or MCRB? BriaCell Therapeutics has higher earnings, but lower revenue than Seres Therapeutics. Seres Therapeutics is trading at a lower price-to-earnings ratio than BriaCell Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBriaCell TherapeuticsN/AN/A-$4.79M-$1.17-0.99Seres Therapeutics$126.32M1.15-$113.72M-$0.23-3.71 Does the MarketBeat Community prefer BCTX or MCRB? Seres Therapeutics received 520 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. However, 100.00% of users gave BriaCell Therapeutics an outperform vote while only 72.01% of users gave Seres Therapeutics an outperform vote. CompanyUnderperformOutperformBriaCell TherapeuticsOutperform Votes10100.00% Underperform VotesNo VotesSeres TherapeuticsOutperform Votes53072.01% Underperform Votes20627.99% Do analysts recommend BCTX or MCRB? BriaCell Therapeutics presently has a consensus target price of $15.00, indicating a potential upside of 1,189.77%. Seres Therapeutics has a consensus target price of $5.08, indicating a potential upside of 495.52%. Given BriaCell Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe BriaCell Therapeutics is more favorable than Seres Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BriaCell Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Seres Therapeutics 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 SummaryBriaCell Therapeutics beats Seres Therapeutics on 9 of the 15 factors compared between the two stocks. Ad True Market InsidersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the #1 Crypto of 2024>3-Cent Amazon Coin< Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCTX vs. The Competition Export to ExcelMetricBriaCell TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$42.08M$6.54B$4.98B$9.16BDividend YieldN/A8.10%7.70%4.06%P/E Ratio-0.994.5977.2913.39Price / SalesN/A362.371,377.39159.82Price / CashN/A22.4934.4035.60Price / Book-7.755.644.825.00Net Income-$4.79M$148.34M$114.44M$223.10M7 Day Performance4.77%4.63%6.65%3.84%1 Month Performance67.34%1.59%122.41%9.76%1 Year Performance-75.36%26.72%157.30%31.90% BriaCell Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTXBriaCell Therapeutics3.3636 of 5 stars$1.16+21.5%$15.00+1,189.8%-79.7%$42.08MN/A-0.9916MCRBSeres Therapeutics3.6065 of 5 stars$0.88-10.1%$5.08+476.7%-24.5%$150.49M$126.32M-3.83233NBTXNanobiotix2.6922 of 5 stars$3.15-2.5%$11.50+265.1%-47.7%$148.47M$36.22M0.00100Gap DownIVAInventiva2.5473 of 5 stars$2.69+1.5%$13.25+392.6%-41.8%$141.16M$15.62M0.00100Gap DownIFRXInflaRx2.753 of 5 stars$2.38-3.3%$8.00+236.1%+81.9%$140.14M$168,498.00-2.2860Positive NewsSKYESkye Bioscience1.5273 of 5 stars$4.49+5.4%$18.67+315.7%+6.3%$136.22MN/A0.0011Positive NewsRPTXRepare Therapeutics3.1689 of 5 stars$3.20-2.4%$10.00+212.5%-50.4%$136.04M$66.52M-1.64180RENBRenovaro0.631 of 5 stars$0.84+11.7%N/A-49.3%$134.10MN/A-0.7912News CoverageGap UpTELOTelomir PharmaceuticalsN/A$4.22+6.0%N/AN/A$124.95MN/A0.001Gap UpHigh Trading VolumeIMUXImmunic2.9028 of 5 stars$1.36+9.3%$11.80+770.8%+8.5%$122.06MN/A0.0070CNTXContext Therapeutics2.828 of 5 stars$1.61+5.9%$6.80+322.4%+72.4%$120.75MN/A-1.677Positive News Related Companies and Tools Related Companies MCRB Alternatives NBTX Alternatives IVA Alternatives IFRX Alternatives SKYE Alternatives RPTX Alternatives RENB Alternatives TELO Alternatives IMUX Alternatives CNTX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BCTX) was last updated on 12/9/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWaveBot: The Automated Trading Tool for This Bull MarketThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCTX Stock Alerts